WO2008118469A3 - Variantes génétiques associées à la restriction de la maladie vih - Google Patents

Variantes génétiques associées à la restriction de la maladie vih Download PDF

Info

Publication number
WO2008118469A3
WO2008118469A3 PCT/US2008/003964 US2008003964W WO2008118469A3 WO 2008118469 A3 WO2008118469 A3 WO 2008118469A3 US 2008003964 W US2008003964 W US 2008003964W WO 2008118469 A3 WO2008118469 A3 WO 2008118469A3
Authority
WO
WIPO (PCT)
Prior art keywords
variants associated
hiv disease
restriction
genetics
genetics variants
Prior art date
Application number
PCT/US2008/003964
Other languages
English (en)
Other versions
WO2008118469A2 (fr
Inventor
David B Goldstein
Amalio Telenti
Jacques Fellay
Kevin V Shianna
Dongliang Ge
Barton F Haynes
Original Assignee
Univ Duke
Univ Lausanne
David B Goldstein
Amalio Telenti
Jacques Fellay
Kevin V Shianna
Dongliang Ge
Barton F Haynes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke, Univ Lausanne, David B Goldstein, Amalio Telenti, Jacques Fellay, Kevin V Shianna, Dongliang Ge, Barton F Haynes filed Critical Univ Duke
Priority to JP2010500973A priority Critical patent/JP2010522560A/ja
Priority to EP08727164A priority patent/EP2121985A4/fr
Priority to CA002680834A priority patent/CA2680834A1/fr
Priority to AU2008231305A priority patent/AU2008231305A1/en
Publication of WO2008118469A2 publication Critical patent/WO2008118469A2/fr
Publication of WO2008118469A3 publication Critical patent/WO2008118469A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • AIDS & HIV (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne, en général, le virus de l'immunodéficience humaine (VIH), et en particulier, des variantes génétiques associées à la restriction de la progression de la maladie VIH.
PCT/US2008/003964 2007-03-27 2008-03-27 Variantes génétiques associées à la restriction de la maladie vih WO2008118469A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2010500973A JP2010522560A (ja) 2007-03-27 2008-03-27 Ｈｉｖ疾患制限に関連する遺伝的変異体
EP08727164A EP2121985A4 (fr) 2007-03-27 2008-03-27 Variantes génétiques associées à la restriction de la maladie vih
CA002680834A CA2680834A1 (fr) 2007-03-27 2008-03-27 Variantes genetiques associees a la restriction de la maladie vih
AU2008231305A AU2008231305A1 (en) 2007-03-27 2008-03-27 Genetics variants associated with HIV disease restriction

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US90727107P 2007-03-27 2007-03-27
US60/907,271 2007-03-27
US92943207P 2007-06-27 2007-06-27
US60/929,432 2007-06-27

Publications (2)

Publication Number Publication Date
WO2008118469A2 WO2008118469A2 (fr) 2008-10-02
WO2008118469A3 true WO2008118469A3 (fr) 2008-12-24

Family

ID=39789200

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/003964 WO2008118469A2 (fr) 2007-03-27 2008-03-27 Variantes génétiques associées à la restriction de la maladie vih

Country Status (5)

Country Link
EP (1) EP2121985A4 (fr)
JP (1) JP2010522560A (fr)
AU (1) AU2008231305A1 (fr)
CA (1) CA2680834A1 (fr)
WO (1) WO2008118469A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105316417B (zh) * 2015-11-27 2018-11-30 北京泱深生物信息技术有限公司 Znrd1基因及其表达产物作为颅内动脉瘤的诊治靶标
BR112019012203A2 (pt) * 2016-12-14 2019-11-12 Beijing Genomics Inst At Shenzhen marcadores genéticos humanos associados à resposta para tratamentos que têm como alvo a toxina b de clostridium difficile

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005332331A1 (en) * 2004-11-26 2006-12-07 Board Of Regents, The University Of Texas System Methods and compositions for correlating CCL3L1/CCR5 genotypes with disorders

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FELLAY ET AL.: "A whole-genome association study of major determinant for host control of HIV-1", SCIENCE, vol. 317, no. 5840, August 2007 (2007-08-01), pages 944 - 947, XP002551832 *
See also references of EP2121985A4 *

Also Published As

Publication number Publication date
AU2008231305A1 (en) 2008-10-02
WO2008118469A2 (fr) 2008-10-02
JP2010522560A (ja) 2010-07-08
CA2680834A1 (fr) 2008-10-02
EP2121985A4 (fr) 2011-01-05
EP2121985A2 (fr) 2009-11-25

Similar Documents

Publication Publication Date Title
IL281111A (en) Preparations for imparting resistance to viral diseases in social insects, and their use
USD624989S1 (en) Single-handle deck-mount faucet
USD660054S1 (en) Seating unit
USD660055S1 (en) Seating unit
USD625507S1 (en) Folding canopy
USD673858S1 (en) Container
WO2008045238A3 (fr) Peptides antiviraux hélicoïdaux courts thérapeutiques stabilisés
USD627395S1 (en) Set of alphabet figures
USD644532S1 (en) Personal care bottle
EP1848837A4 (fr) Stabilite de verre amelioree, capacite de formation de verre, et affinage microstructurel
CA119221S (en) Blister package
WO2011012316A3 (fr) Arn ayant une combinaison de nucléotides non modifiés et modifiés pour l'expression protéique
WO2008014200A3 (fr) Compositions de cyclosporine
CA125775S (en) Jar
WO2008151032A3 (fr) Ensembles et procédés comprenant des produits géniques de m. smithii
USD662200S1 (en) Nasal interface
WO2011049914A3 (fr) Peptides anti-vih et méthodes d'utilisation
WO2009099467A3 (fr) Compositions de cyclosporine
USD675397S1 (en) Pair of sleeves
WO2008088747A3 (fr) Procédé de surveillance d'une infection par le vih
USD687556S1 (en) BOXER'S fracture brace
EP2017355A4 (fr) Gène associé à une maladie artérioscléreuse et utilisation de celui-ci
USD635790S1 (en) Chair
WO2010046061A3 (fr) Préparations cosmétiques et/ou pharmaceutiques
WO2010064822A3 (fr) Lutte efficace contre une maladie virale des plantes avec des souches de pseudomonas oleovorans

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08727164

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
ENP Entry into the national phase

Ref document number: 2680834

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2010500973

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2008727164

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008231305

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2008231305

Country of ref document: AU

Date of ref document: 20080327

Kind code of ref document: A

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)